HB
GILD icon

Homrich & Berg’s Gilead Sciences GILD Stock Holding History

Homrich & Berg’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$352K Sell
5,041
-183
-4% -$12.9K 0.01% 339
2021
Q2 		$360K Sell
5,224
-2,024
-28% -$135K 0.01% 338
2021
Q1 		$468K Sell
7,248
-12,012
-62% -$775K 0.01% 281
2020
Q4 		$1.12M Sell
19,260
-4,993
-21% -$301K 0.03% 185
2020
Q3 		$1.53M Buy
24,253
+3,774
+18% +$262K 0.05% 121
2020
Q2 		$1.58M Buy
20,479
+7,070
+53% +$542K 0.06% 98
2020
Q1 		$1M Buy
13,409
+4,320
+48% +$299K 0.06% 122
2019
Q4 		$591K Sell
9,089
-1,128
-11% -$73.5K 0.03% 213
2019
Q3 		$648K Buy
10,217
+254
+3% +$16.6K 0.03% 191
2019
Q2 		$673K Buy
9,963
+1,248
+14% +$82.1K 0.04% 183
2019
Q1 		$567K Buy
8,715
+4,055
+87% +$270K 0.03% 193
2018
Q4 		$291K Buy
4,660
+265
+6% +$18.5K 0.02% 247
2018
Q3 		$339K Buy
4,395
+16
+0.4% +$1.21K 0.02% 255
2018
Q2 		$310K Sell
4,379
-2,454
-36% -$173K 0.02% 253
2018
Q1 		$515K Sell
6,833
-804
-11% -$63.9K 0.04% 205
2017
Q4 		$547K Buy
7,637
+60
+0.8% +$4.56K 0.04% 194
2017
Q3 		$614K Buy
7,577
+911
+14% +$69.7K 0.05% 168
2017
Q2 		$472K Sell
6,666
-147
-2% -$9.78K 0.04% 172
2017
Q1 		$463K Buy
6,813
+3,276
+93% +$230K 0.04% 180
2016
Q4 		$253K Buy
3,537
+539
+18% +$40.1K 0.02% 239
2016
Q3 		$237K Sell
2,998
-434
-13% -$35.3K 0.02% 248
2016
Q2 		$286K Sell
3,432
-50
-1% -$4.44K 0.03% 205
2016
Q1 		$320K Sell
3,482
-573
-14% -$51.7K 0.03% 187
2015
Q4 		$410K Sell
4,055
-383
-9% -$39.9K 0.04% 168
2015
Q3 		$436K Buy
4,438
+530
+14% +$58.9K 0.05% 152
2015
Q2 		$458K Buy
3,908
+211
+6% +$23.1K 0.04% 161
2015
Q1 		$363K Buy
3,697
+535
+17% +$54.3K 0.04% 180
2014
Q4 		$298K Sell
3,162
-9,165
-74% -$948K 0.03% 189
2014
Q3 		$1.31M Buy
12,327
+9,748
+378% +$955K 0.13% 61
2014
Q2 		$214K Buy
+2,579
New +$201K 0.02% 193

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Homrich & Berg's GILD Position: Q3 2021 in Review

Homrich & Berg reduced its Gilead Sciences (GILD) stake by 3.5% in Q3 2021, selling an estimated $12.9K and leaving 5,041 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #339.

Homrich & Berg first reported a position in GILD in Q2 2014 and has held it in 30 quarters since. The position peaked at $1.58M in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Homrich & Berg held 5,041 shares of Gilead Sciences worth $352K as of Q3 2021.
  • Homrich & Berg sold 183 Gilead Sciences shares in Q3 2021, an estimated $12.9K.
  • Gilead Sciences made up 0.01% of Homrich & Berg's portfolio in Q3 2021, its #339 holding.
  • Homrich & Berg first reported a position in Gilead Sciences in Q2 2014 and has held it in 30 quarters since.
  • Homrich & Berg's Gilead Sciences position peaked at $1.58M in Q2 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.